Zura Bio (ZURA) analyst forecast and price target
Analyst forecast
Consensus of 8 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Guggenheim | Maintained | Buy | $20.00 from $15.00 | Aug 12, 2026 |
| Wedbush | Maintained | Outperform | $22.00 from $15.00 | Aug 12, 2026 |
| William Blair | Initiated Coverage | Outperform | — | Jul 8, 2026 |
| Wedbush | Maintained | Outperform | $15.00 | Jul 1, 2026 |
| Chardan Capital | Maintained | Buy | $11.00 from $10.00 | Mar 23, 2026 |
| Oppenheimer | Maintained | Outperform | $15.00 from $16.00 | Mar 20, 2026 |
| Wedbush | Initiated Coverage | Outperform | $15.00 | Feb 9, 2026 |
| Chardan Capital | Maintained | Buy | $10.00 | Nov 14, 2025 |
| Clear Street | Initiated Coverage | Buy | $18.00 | Nov 13, 2025 |
| Chardan Capital | Maintained | Buy | $10.00 | Sep 30, 2025 |
| HC Wainwright & Co. | Maintained | Neutral | $2.00 from $3.00 | Aug 19, 2025 |
| Chardan Capital | Maintained | Buy | $10.00 | Aug 15, 2025 |
| Oppenheimer | Maintained | Outperform | $16.00 from $17.00 | Aug 15, 2025 |
| Oppenheimer | Maintained | Outperform | $17.00 from $19.00 | May 9, 2025 |
| HC Wainwright & Co. | Maintained | Neutral | $3.00 from $5.00 | Apr 3, 2025 |
| Chardan Capital | Maintained | Buy | $10.00 from $12.00 | Mar 26, 2025 |
| Guggenheim | Maintained | Buy | $15.00 | Mar 26, 2025 |
| Oppenheimer | Maintained | Outperform | $19.00 from $20.00 | Mar 26, 2025 |
| HC Wainwright & Co. | Maintained | Neutral | $5.00 | Dec 24, 2024 |
| Cantor Fitzgerald | Maintained | Overweight | — | Dec 11, 2024 |
Frequently asked questions
Is ZURA a buy, sell, or hold?
Analysts covering Zura Bio currently average a Buy rating: 8 buy, 0 hold and 0 sell, from 8 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on ZURA?
On Aug 12, 2026, Guggenheim maintained Zura Bio at Buy with a price target of $20.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.